FDAnews Device Daily Bulletin
Medical Devices / Commercial Operations

Medtronic Buys Up Cardiac Ablation Developer EPIX Therapeutics

Jan. 29, 2019

Medtronic has entered into an agreement with EPIX Therapeutics in Santa Clara, California to acquire the company — a move that expands its presence in the fast-growing catheter ablation market.

EPIX’s main product, the DiamondTemp ablation system, is a temperature-controlled system that physicians can use for improved control and feedback during cardiac ablation procedures. It uses radiofrequency energy to make scar tissue in the heart.

The DiamondTemp system received a CE Mark in 2017 and is currently in an investigational device evaluation study in the U.S.

The acquisition is expected to become final by April 26 if all conditions are met.

View today's stories